Perspective of Soy Formula and Fiber intake among Non-Cow’s Milk Drinker Pediatric Patients; A Survey among Indonesian Health Care Practitioners

Ray Wagiu Basrowi, Erika Wasito, Tonny Sundjaya

Abstract


Indonesia is one of the highest countries for soy-based product consumption, which the usage also started from early age as breastmilk substitute product, although local regulation and guideline stated that soy-based formula recommended for cow’s milk protein allergy. However, evidences showed that soy-based formula supplemented with fiber in non-cow’s milk drinker could also have health effect to gastrointestinal system. This online survey aimed to explore the perspective of health care practitioners (HCPs) in recommending soy-based formula for non-cow’s milk drinker pediatric patients, as well as identify the required additional ingredient or supplementation, specifically on fiber, in soy-based formula. Majority of respondents (97% of paediatricians (P < 0.001)), (96% of nurses  (P = 0.003)), (99% of midwives (P < 0.001)) recommended soy-based formula as nutritional product toward non-cow’s milk drinker patients. On the added ingredients required, 43% of respondents mentioned that AA and DHA and 31% mentioned that fibre is the ingredient that need to be added to complete the benefits of soy formula. This study concluded that the overall perspective of HCPs showed that soy-based formula is a nutritional product recommended for non-cow’s milk pediatric patients. However, fiber is required to be added to achieve the potential benefits of soy-based formula.


Keywords


Soy Formula; Fiber; Paediatric;

Full Text:

V04.S1.0002

References


Hill LW, Stuart HC. A soy bean food preparation for feeding infants with milk idiosyncrasy. J. Am. Med. Assoc 1929;93:985. [Google Scholar]

Ikatan Dokter Indonesia (IDAI). Rekomendasi Diagnosis dan Tatalaksana Alergi Susu Sapi. Badan Penerbit Ikatan Dokter Anak Indonesia (2014): Jakarta

BPOM RI. Peraturan Badan Pengawas Obat dan Makanan Nomor 1/2008 tentang Pengawasan Pangan Olahan untuk keperluan gizi khusus. BPOM Republik Indonesia. 2008

Finn K, Jacquier E, Kineman B, Storm H, Carvalho R. Nutrient intakes and sources of fiber among children with low and high dietary fiber intake: the 2016 feeding infants and toddlers study (FITS), a cross-sectional survey. BMC Pediatr 2019;19(1):446. doi: 10.1186/s12887-019-1822-y. [Google Scholar]

Chen HL, Haack VS, Janecky CW, Vollendorf NW, Marlett JA. Mechanisms by which wheat bran and oat bran increase stool weight in humans. Am J Clin Nutr 1998;68(3):711. doi: 10.1093/ajcn/68.3.711. [Google Scholar]

Yu K, Ke MY, Li WH, Zhang SQ, Fang XC. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes. Asia Pac J Clin Nutr 2014;23(2):210. [Google Scholar]

Wu K, Bowman R, Welch AA, Luben RN, Wareham N, Khaw KT, et al. Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. Eur Heart J 2007;28(23):2930. doi: 10.1093/eurheartj/ehm482. [Google Scholar]

Vanderhoof J, Murray ND, Paule CL, Ostrom KM. Use of soy fiber in acute diarrhea in infants and toddlers. Clinical pediatrics 1997;36(3):135-9. [Google Scholar]

Rizzo G, Baroni L. Soy, soy foods and their role in vegetarian diets. Nutrients 2018;10(1):43. [Google Scholar]

O’Keefe S, Bianchi L, Sharman J. Soybean Nutrition. Nutr Metab (Lond 2015;1(2):1006. [Google Scholar]

Al-Azri H, Ratnapalan S. Problem-based learning in continuing medical education: review of randomized controlled trials. Canadian family physician 2014 Feb;60(2):157-65. [Google Scholar]

Marinopoulos SS, Baumann MH. Effectiveness of Continuing Medical Education: American College of Chest Physicians Evidence-Based Educational Guidelines. CHEST 2009;135:17. [Google Scholar]

Ahmed K, Wang TT, Ashrafian H, Layer GT, Darzi A, Athanasiou T. The Effectiveness of Continuing Medical Education for Specialist Resertification. Can Urol Assoc J 2013;7(7-8):266. [Google Scholar]

Basrowi RW, Krisnamurti D, Wibowo Y, Vandenplas Y (2019) Factors influencing probiotics recommendation among pediatricians in Indonesia . . 2019;6:1-4. doi: 10.15761/IFNM.1000265. [Google Scholar]

Reynaldo A, Hegar B. Soy Infant and Extensively Hydrolyzed Formula as Therapeutic Formula for Cow’s Milk Protein Allergy. The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy 2014;15(2):98-104. [Google Scholar]

World Health Organization (WHO). Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants. CODEX STAN 72-1981 Rev 2017

Vandenplas Y, Greef, E. De , Devreker T, Hauser B. Soy Infant Formula: is it that bad. Acta Paediatrica 2011;100:162-66. [Google Scholar]

Vandenplas Y, Munasir Z, Hegar B, Kumarawati D, Suryawan A, Kadim M, et al. 2019). A perspective on partially hydrolyzed protein infant formula in nonexclusively breastfed infants. Korean J Pediatri;2019: 62(5):149–154 Vandenplas Y, Munasir Z, Hegar B, Kumarawati D, Suryawan A, Kadim M, Djais JT, Basrowi RW, Krisnamurti D. A perspective on partially hydrolyzed protein infant formula in nonexclusively breastfed infants. Korean journal of pediatrics 2019;62(5):149-54. [Google Scholar]

Lasekan J, Baggs G, Acosta S, et al. Soy Protein-Based Infant Formulas with Supplemental Fructooligosaccharides: Gastrointestinal Tolerance and Hydration Status in Newborn Infants. Nutrients 2015;7:3022-3037. doi: 10.3390/nu7043022. [Google Scholar]

Orel R, ReberŠak L. Clinical Effects of Prebiotics in Pediatric Population. Indian Pediatr 2016;53:1083-1093. [Google Scholar]

Hegar B, Wibowo Y, Basrowi RW, Ranuh RG, Sudarmo SM, Munasir Z, et al. The Role of Two Human Milk Oligosaccharides, 2'-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition. Pediatr Gastroenterol Hepatol Nutr 2019;22(4):330-340. doi: 10.5223/pghn.2019.22.4.330. [Google Scholar]




DOI: https://doi.org/10.25220/WNJ.V04.S1.0002

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Ray Wagiu Basrowi, Erika Wasito, Tonny Sundjaya

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

View My Stats